YU251977A - Process for obtaining n-substituted lactams - Google Patents

Process for obtaining n-substituted lactams

Info

Publication number
YU251977A
YU251977A YU02519/77A YU251977A YU251977A YU 251977 A YU251977 A YU 251977A YU 02519/77 A YU02519/77 A YU 02519/77A YU 251977 A YU251977 A YU 251977A YU 251977 A YU251977 A YU 251977A
Authority
YU
Yugoslavia
Prior art keywords
obtaining
substituted lactams
lactams
substituted
Prior art date
Application number
YU02519/77A
Other languages
English (en)
Inventor
L Rodriguez
L Marchal
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of YU251977A publication Critical patent/YU251977A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
YU02519/77A 1976-10-22 1977-10-20 Process for obtaining n-substituted lactams YU251977A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43934/76A GB1539817A (en) 1976-10-22 1976-10-22 N-substituted lactams

Publications (1)

Publication Number Publication Date
YU251977A true YU251977A (en) 1983-01-21

Family

ID=10431009

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02519/77A YU251977A (en) 1976-10-22 1977-10-20 Process for obtaining n-substituted lactams

Country Status (27)

Country Link
US (1) US4162325A (fr)
JP (1) JPS5839148B2 (fr)
AT (1) AT352742B (fr)
BE (1) BE859925A (fr)
BG (1) BG28413A3 (fr)
CA (1) CA1095040A (fr)
CH (1) CH625214A5 (fr)
CS (1) CS200231B2 (fr)
CY (1) CY1037A (fr)
DD (1) DD131930A5 (fr)
DE (1) DE2747369A1 (fr)
DK (1) DK461877A (fr)
ES (1) ES463424A1 (fr)
FI (1) FI66600C (fr)
FR (1) FR2368474B1 (fr)
GB (1) GB1539817A (fr)
HK (1) HK2380A (fr)
HU (1) HU174864B (fr)
IL (1) IL53171A (fr)
KE (1) KE3013A (fr)
MY (1) MY8000264A (fr)
NL (1) NL7711414A (fr)
PL (1) PL110679B1 (fr)
SE (1) SE425782B (fr)
SU (2) SU805945A3 (fr)
YU (1) YU251977A (fr)
ZA (1) ZA776260B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2960194D1 (en) * 1978-05-08 1981-04-16 Ucb Sa Lactam-n-acetic acids, their amides, process for their preparation and therapeutic compositions containing them
EP0115473A3 (fr) * 1983-01-27 1987-01-21 Ciba-Geigy Ag Dérivés substitués de pyrrolidinone et leur procédé de préparation
EP0115472A3 (fr) * 1983-01-27 1985-10-02 Ciba-Geigy Ag Dérivés de la pyrrolidinone et leur procédé de préparation
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0419683A4 (en) * 1989-04-13 1992-03-11 Japan Tobacco Inc. New amino acid derivatives having prolylendopeptidase inhibitor activity
US5206386A (en) * 1991-03-20 1993-04-27 Isp Investments Inc. Controlled release N-substituted pyrrolidone esters and process for the use thereof
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
CN114685342B (zh) * 2020-12-25 2024-05-10 长沙博源医疗科技有限公司 一种左乙拉西坦衍生物、免疫原、抗左乙拉西坦特异性抗体及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121723A (en) * 1955-11-02 1964-02-18 Sterling Drug Inc Lower alkyl n-(tertiary-amino-lower-alkyl) lower alkamates and quaternary ammonium salts thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
NL7407140A (nl) * 1974-03-07 1975-09-09 Jose Maria Espinos Taya En Jos Werkwijze voor de bereiding van een n-gesub- stitueerd pyrrolidon.
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins

Also Published As

Publication number Publication date
ZA776260B (en) 1978-07-26
GB1539817A (en) 1979-02-07
SU937450A1 (ru) 1982-06-23
DE2747369A1 (de) 1978-04-27
PL110679B1 (en) 1980-07-31
HU174864B (hu) 1980-03-28
FR2368474A1 (fr) 1978-05-19
BG28413A3 (en) 1980-04-15
IL53171A0 (en) 1977-12-30
US4162325A (en) 1979-07-24
FR2368474B1 (fr) 1980-08-08
DD131930A5 (de) 1978-08-09
AT352742B (de) 1979-10-10
JPS5353649A (en) 1978-05-16
PL201601A1 (pl) 1979-01-29
CY1037A (en) 1980-08-01
ES463424A1 (es) 1978-07-16
FI66600C (fi) 1984-11-12
CH625214A5 (fr) 1981-09-15
BE859925A (fr) 1978-04-20
DK461877A (da) 1978-04-23
ATA749677A (de) 1979-03-15
NL7711414A (nl) 1978-04-25
IL53171A (en) 1982-02-28
MY8000264A (en) 1980-12-31
DE2747369C2 (fr) 1987-11-12
JPS5839148B2 (ja) 1983-08-27
FI773069A (fi) 1978-04-23
FI66600B (fi) 1984-07-31
CS200231B2 (en) 1980-08-29
SU805945A3 (ru) 1981-02-15
HK2380A (en) 1980-01-25
CA1095040A (fr) 1981-02-03
SE425782B (sv) 1982-11-08
SE7711667L (sv) 1978-04-23
KE3013A (en) 1980-02-01

Similar Documents

Publication Publication Date Title
YU41020B (en) Process for preparing heterocyclic phenylet
CS187003B1 (en) Process for preparing polyamides
YU42888B (en) Process for obtaining indolysine derivatives
JPS52110795A (en) Process for polyynnbutene
YU76477A (en) Process for obtaining nitrogen-containing polyasaccharides
YU146977A (en) Process for obtaining gamma-pyrone
YU251977A (en) Process for obtaining n-substituted lactams
GB1554516A (en) Process for preparing an amine
YU143177A (en) Process for obtaining sulfinyl-chloride
YU94877A (en) Process for obtaining naphthiridine derivatives
GB1554515A (en) Process for preparing an amine
YU162577A (en) Process for obtaining guaiacol-p-isobutyl-hydrotropate
YU179677A (en) Process for preparing n-substituted ethyleneamino-dithiocarbamates
GB1554372A (en) Process for preparing an amine
YU39669B (en) Process for obtaining triphenylalkene derivatives
YU40314B (en) Process for obtaining thymosine
JPS53101312A (en) Process for preparing haloacyl amide
YU40169B (en) Process for obtaining thiochromane derivatives
JPS53105422A (en) Process for preparing alphaaketocarboxylic amide
JPS5326796A (en) Process for preparing alkalimetal amide
YU141877A (en) Process for obtaining hydrazinopyridazine derivatives
YU20577A (en) Process for obtaining triphenylalkene derivatives
CS191496B1 (en) Process for preparing n-substituted lactames
YU12477A (en) Process for obtaining flavium-chloride
YU309777A (en) Process for obtaining n-substituted 2-amino-cyclopent-1-ene-1-dithiocarboxylic acids